CRISPR Delivery and Manufacturing Innovation for Minimal-COG Cancer and HIV Therapies Via In Vivo Immune Engineering: a First-In-Class Industry-Academia Partnership
Global Life Science Solutions USA LLC (d.b.a Cytiva) in Marlborough, Mass. intends to advance a nanoparticle-based platform for in vivo gene editing to treat and eliminate gastrointestinal cancers.